Stockscreener 앱 받기
2.29
6.51%
0.14
시간 외 거래:
2.37
0.08
+3.49%
Apyx Medical Corp 주식(APYX)의 최신 뉴스
Citadel Advisors LLC Increases Stock Position in Apyx Medical Co. (NASDAQ:APYX) - Defense World
Northern Trust Corp Raises Holdings in Apyx Medical Co. (NASDAQ:APYX) - Defense World
Apyx Medical Co. (NASDAQ:APYX) Short Interest Up 59.8% in May - Defense World
Renuvion® Brings Real Transformations to the Runway at Miami Swim Week - Stock Titan
Apyx Medical First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Raymond James Financial Inc. Takes Position in Apyx Medical Co. (NASDAQ:APYX) - Defense World
APYX Secures FDA Clearance for AYON Body Contouring System | APY - GuruFocus
Apyx Medical wins FDA clearance for body contouring tech - Yahoo Finance
Apyx Medical Corporation (NASDAQ:APYX) Q1 2025 Earnings Call Transcript - Insider Monkey
Apyx Medical gets FDA nod for AYON Body Contouring System - Investing.com
Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™ - GlobeNewswire
Apyx Medical Corporation (NASDAQ:APYX) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
Apyx Medical Corp SEC 10-Q Report - TradingView
SEC Form 10-Q filed by Apyx Medical Corporation - Quantisnow
Earnings call transcript: Apyx Medical beats Q1 2025 expectations, stock rises - Investing.com Nigeria
Apyx Medical earnings beat by $0.02, revenue topped estimates - Investing.com
Apyx Medical Corporation Reports First Quarter 2025 Financial Results - The Manila Times
Apyx Medical Corp (APYX) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Apyx Medical Corp expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Form 8-KCurrent report - ADVFN
Renuvion Introduces Television Star Dolores Catania as Chief of Confidence - Stock Titan
Apyx Medical (APYX) Highlighted in New Clinical Studies on Renuv - GuruFocus
Apyx Medical Co. (NASDAQ:APYX) Short Interest Update - Defense World
Apyx Medical Corporation Announces Two Peer-Reviewed - GlobeNewswire
Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures - Yahoo Finance
Apyx Medical Corp. to Host Earnings Call - ACCESS Newswire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025 - Quantisnow
Apyx Medical Sets Q1 Earnings Date: Latest Results Coming for Renuvion Plasma Technology Maker - Stock Titan
Reviewing Haemonetics (NYSE:HAE) and Apyx Medical (NASDAQ:APYX) - Defense World
Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener" - Quantisnow
Apyx Medical’s SWOT analysis: helium-based plasma tech stock faces market headwinds - Investing.com
Apyx Medical (NASDAQ:APYX) & Bluejay Diagnostics (NASDAQ:BJDX) Head-To-Head Review - Defense World
Commonwealth Equity Services LLC Has $833,000 Holdings in Apyx Medical Co. (NASDAQ:APYX) - Defense World
Citizens JMP maintains Apyx Medical stock at Market Perform - Investing.com Australia
Reviewing Apyx Medical (NASDAQ:APYX) and PetVivo (NASDAQ:PETV) - Defense World
Liposuction Surgery Devices Market Growth Report and - GlobeNewswire
Liposuction Surgery Devices Market Growth Report and Company Analysis 2025-2033 Featuring SOLTA MEDICAL, InMode, Genesis Biosystems, Hologic, Apyx Medical, Cynosure, YOLO Medical, and Sciton - Yahoo Finance
APYX DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Apyx Medical Corporation Investors to Secure Counsel Before Important August 5 Deadline in Securities Class Action – APYX - Business Wire
Apyx Medical Corporation (NASDAQ:APYX) Q4 2024 Earnings Call Transcript - Insider Monkey
Apyx Medical Corp (APYX) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... By GuruFocus - Investing.com Canada
Apyx Medical Reports 2024 Financial Results and Strategic Plans - TipRanks
APYX stock touches 52-week low at $0.96 amid market challenges - Investing.com Australia
Apyx Medical’s Mixed Earnings Call: Opportunities and Challenges - TipRanks
APYX stock touches 52-week low at $0.96 amid market challenges By Investing.com - Investing.com South Africa
Earnings call transcript: Apyx Medical Q4 2024 beats EPS forecast, stock rises By Investing.com - Investing.com South Africa
Apyx Medical reports Q4 EPS (12c), consensus (16c) - TipRanks
Earnings call transcript: Apyx Medical Q4 2024 beats EPS forecast, stock rises - Investing.com
Apyx Medical Corp reports results for the quarter ended December 31Earnings Summary - TradingView
0.19%
자본화:
|
볼륨(24시간):